A Phase IIa Clinical Study of RG002C0106 Injection in Subjects With Primary IgA Nephropathy

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This study looks at how well and safely RG002C0106 works for patients with certain kidney disease: primary IgA nephropathy. It\'s a phase IIa trial done at several locations where both patients and doctors unknow what treatment is being given.
Epistemonikos ID: 3d1af39d3756def01e71bade47b173d7350e7b0c
First added on: Dec 27, 2025